Preparing
14 results
Applied filters
Risk assessment of preparation of monoclonal antibodies
27 June 2025A systematic approach to occupational risk assessment informs decisions about safe working practices with monoclonal antibodies (mAb)
Occupational exposure to monoclonal antibodies
27 June 2025Understanding potential exposure to monoclonal antibodies (mAb) informs the occupational risk assessment
Safe handling of monoclonal antibodies
27 June 2025Considerations for occupational safety when preparing monoclonal antibodies (mAb)
Choosing between oral vancomycin options
18 June 2025Organisations should choose suitable formulary options for oral vancomycin and mitigate risks. Several factors affect decision making.
Choosing between fidaxomicin options
18 June 2025Organisations should choose suitable fidaxomicin formulary options and mitigate risks. Several factors affect decision making.
How to perform preparation risk assessments for ATMPs
10 April 2024Preparation risk assessment tools for cell and tissue-based Advanced Therapy Medicinal Products (ATMPs) and in-vivo Gene Therapies.
Requirements for Governance and Preparation of Gene Therapy
6 February 2024Practical advice for centres implementing Gene Therapies detailing Governance requirements and optimal preparation location decision making support.
Preparing eye drops in unlicensed aseptic units
17 October 2023Circumstances and potential risks should be considered before preparing eye drops in NHS aseptic units working under Section 10 exemption.
Managing the risks of using effervescent tablets in children
9 March 2023Careful use of effervescent or soluble tablets to deliver part tablet doses for children and neonates can minimise risks of toxicity or suboptimal therapy.
Labelling and packaging of unlicensed medicines (Specials): best practice guidance for the NHS
1 March 2022National guidance from NHSE/I to reduce LASA errors and improve patient safety when considering requirements for unlicensed specials medicines